The Medical Futurist

JUNE 17, 2025

Just like in the case of other medical specialties , disruptive innovations will have a huge impact on how dentistry will be practiced and how patients will take care of themselves in the future. For patients, it promises more accurate care and better outcomes. How about having a teledentist consultation?

Patients 126

Patients Treatment Plan Healthcare Medical Specialty 126

FDA Law Blog

MARCH 1, 2023

By way of background, FDA first proposed using a QMM rating in its 2019 Report on Drug Shortages and Potential Solutions. The QMM rating is based on an evaluation of a facility’s quality practices and it is meant to be a leading indicator for detecting problems before they occur, such as a drug shortage.

Management 45

Management Manufacturing Supply Chain Provider 45

FDA Law Blog

FEBRUARY 16, 2023

sales of naloxone from a wholesale distributor to a harm reduction program) from certain requirements under the Drug Supply Chain Security Act. mistakenly administered to a patient who is not experiencing an overdose), and (3) an Rx-to-OTC switch for NNS will save lives.

Supply Chain 64

Supply Chain Healthcare Professional Community IT 64

BMJ

AUGUST 20, 2021

doi: 10.1136/fmch-2021-001143 The COVID-19 pandemic has resulted in profound changes in patient and prescriber behaviour. In the United Kingdom (UK), primary care practitioners are the first-line clinicians which most patients encounter, providing initial assessment and treatment of a wide variety of conditions.

Primary Care 40

Primary Care Supply Chain General Practitioner Vaccination 40

FDA Law Blog

SEPTEMBER 13, 2021

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. ADMINISTRATIVE ACTIONS.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98